You are here

  • Home
  • Archive
  • Volume 10, Issue 10
  • Efficacy of neoadjuvant atezolizumab treatment in patients with advanced urothelial bladder cancer according to the BASQ classification: a study protocol for an open-label, two-cohort, phase II trial

Citation Tools

Article menu
XML
Urology
Protocol
Efficacy of neoadjuvant atezolizumab treatment in patients with advanced urothelial bladder cancer according to the BASQ classification: a study protocol for an open-label, two-cohort, phase II trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Yuk HD, Jeong CW, Kwak C, et al
Efficacy of neoadjuvant atezolizumab treatment in patients with advanced urothelial bladder cancer according to the BASQ classification: a study protocol for an open-label, two-cohort, phase II trial
BMJ Open 2020;10:e035530. doi: 10.1136/bmjopen-2019-035530